MXCT Insider Trading (MaxCyte)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £222,400
Insider Selling (Last 12 Months): GBX 0
MaxCyte Share Price & Price History
Current Price: GBX 371
Price Change: ▼ Price Decrease of -39 (-9.51%)
As of 06/30/2022 05:00 PM ET
Tailor an Options Trading Strategy to Fit Your Needs
From RJO Futures | Ad
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.
Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.
MaxCyte Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/22/2021 | Richard Douglas | Insider | Buy | 20,000 | GBX 1,112 | £222,400 | | |
| 2/18/2021 | Will Brooke | Insider | Sell | 40,900 | GBX 1,015 | £415,135 | | |
| 2/3/2021 | Stark Thompson | Insider | Sell | 30,000 | GBX 700 | £210,000 | | |
| 10/1/2020 | Stark Thompson | Insider | Sell | 25,000 | GBX 355 | £88,750 | | |
Tailor an Options Trading Strategy to Fit Your Needs
From RJO Futures | Ad
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.
Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.
SEC Filings (Institutional Ownership Changes) for MaxCyte (LON:MXCT)
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Read More on MaxCyte
Today's Range
Now: GBX 371
50 Day Range
MA: GBX 376.25
52 Week Range
Now: GBX 371
Volume
7,144 shs
Average Volume
71,361 shs
Market Capitalization
£376.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of MaxCyte?
